- Mouse Anti-TIGIT/VSTM3/VSIG9 Antibody
- MyBioSource.com
- Pricing InfoSupplier PageView Company Product Page
- MBS4380856
- 0.02 mg (With BSA & Azide at 0.2mg/ml)
- Monoclonal
- ELISA (EIA), Immunohistochemistry (IHC) Paraffin
- Mouse
- 26kDa
- TIGIT/VSTM3/VSIG9
- Purified Ab with BSA and Azide at 200ug/ml OR Purified Ab WITHOUT BSA and Azide at 1.0mg/ml
- T cell immunoreceptor with Ig and ITIM domains
- WUCAM, VSTM3, VSIG9
- Human (Hu)
- IgG2b kappa
- TIGIT/3106
- Unconjugated
- 200ug/ml of Ab Purified from Bioreactor Concentrate by Protein A/G. Prepared in 10mM PBS with 0.05% BSA & 0.05% azide. Also available WITHOUT BSA & azide at 1.0mg/ml
Specifications/Features
TIGIT is a checkpoint inhibitor which binds with high affinity to the poliovirus receptor (PVR), causing increased IL10 secretion, decreased IL12B secretion. TIGIT binding to PVR also causes the suppression of T cell activation by promoting the generation of mature immuno-regulatory dendritic cells. It is expressed at low levels on natural killer (NK) cells, as well as peripheral memory and regulatory CD4+ T cells. At the protein level, it is upregulated following the activation of these cells. Functionally, TIGIT is similar to CTLA4. The ligands for TIGIT include CD155 (signal abrogation) and CD226 (signal stimulation). It has been demonstrated to be upregulated on T cells in many cancers and is a immuno-oncology target for therapy